AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.850
0.00 (0.00%)
Nov 7, 2024, 1:02 PM EST - Market open

AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $33.59 million. The enterprise value is $44.84 million.

Market Cap 33.59M
Enterprise Value 44.84M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date Nov 11, 2024
Ex-Dividend Date n/a

Share Statistics

AEON Biopharma has 39.52 million shares outstanding. The number of shares has decreased by -68.99% in one year.

Current Share Class 39.52M
Shares Outstanding 39.52M
Shares Change (YoY) -68.99%
Shares Change (QoQ) +4.23%
Owned by Insiders (%) 6.13%
Owned by Institutions (%) 5.28%
Float 17.55M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.39

Current Ratio 0.39
Quick Ratio 0.33
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -597.69%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$30.55M
Employee Count 10
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.84% in the last 52 weeks. The beta is 0.40, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y) 0.40
52-Week Price Change -81.84%
50-Day Moving Average 0.93
200-Day Moving Average 4.05
Relative Strength Index (RSI) 38.07
Average Volume (20 Days) 73,573

Short Selling Information

The latest short interest is 153,113, so 0.39% of the outstanding shares have been sold short.

Short Interest 153,113
Short Previous Month 68,653
Short % of Shares Out 0.39%
Short % of Float 0.87%
Short Ratio (days to cover) 0.74

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -43.96M
Pretax Income -323.95M
Net Income -305.52M
EBITDA -43.86M
EBIT -43.96M
Earnings Per Share (EPS) -$7.10
Full Income Statement

Balance Sheet

The company has $3.44 million in cash and $14.69 million in debt, giving a net cash position of -$11.25 million or -$0.28 per share.

Cash & Cash Equivalents 3.44M
Total Debt 14.69M
Net Cash -11.25M
Net Cash Per Share -$0.28
Equity (Book Value) -27.95M
Book Value Per Share -0.71
Working Capital -6.41M
Full Balance Sheet

Cash Flow

Operating Cash Flow -43.40M
Capital Expenditures n/a
Free Cash Flow -43.40M
FCF Per Share -$1.10
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 68.99%
Shareholder Yield 68.99%
Earnings Yield -918.64%
FCF Yield -130.49%

Analyst Forecast

The average price target for AEON Biopharma is $5.00, which is 488.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.00
Price Target Difference 488.24%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3